| Original language | English |
|---|---|
| Number of pages | 1 |
| Journal | Japanese Journal of Leprosy |
| Volume | 58 |
| Issue number | 1 |
| Publication status | Published - 1989 Jan 1 |
Fingerprint
Glycolipids
Leprosy
Drug Therapy
Antibodies
All Science Journal Classification (ASJC) codes
- Dermatology
- Infectious Diseases
Cite this
Kim, D. I., Jeong, K. W., & Cho, S. (1989). The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy. Japanese Journal of Leprosy, 58(1).
@article{0dd0675f43fb43e394f9d938ad2ef8f0,
title = "The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy",
author = "Kim, {D. I.} and Jeong, {K. W.} and Sangnae Cho",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "58",
journal = "Japanese Journal of Leprosy",
issn = "1342-3681",
publisher = "Japanese Leprosy Association",
number = "1",
}
Kim, DI, Jeong, KW & Cho, S 1989, 'The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy', Japanese Journal of Leprosy, vol. 58, no. 1.
The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy. / Kim, D. I.; Jeong, K. W.; Cho, Sangnae.
In: Japanese Journal of Leprosy, Vol. 58, No. 1, 01.01.1989.Research output: Contribution to journal › Article
TY - JOUR
T1 - The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy
AU - Kim, D. I.
AU - Jeong, K. W.
AU - Cho, Sangnae
PY - 1989/1/1
Y1 - 1989/1/1
UR - http://www.scopus.com/inward/record.url?scp=0024507870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024507870&partnerID=8YFLogxK
M3 - Article
VL - 58
JO - Japanese Journal of Leprosy
JF - Japanese Journal of Leprosy
SN - 1342-3681
IS - 1
ER -
Kim DI, Jeong KW, Cho S. The change of phenolic glycolipid 1 and its antibody levels in leprosy patients following the chemotherapy. Japanese Journal of Leprosy. 1989 Jan 1;58(1).